Boris Gorovits

Company: Sana Biotechnology

Job title: Vice President

Seminars:

Industry Leaders Panel Discussion: Addressing High Dose AAV Delivery 9:30 am

Have we reached the highest dose for gene therapy yet? Exploring dosing strategies: “One and done or Slower and Lower?” What impact would a cumulative vector genome delivery approach have on safety and efficacy? Moving away from one and done: what does best practice look like for dosing strategies? Which role does complement play in…Read more

day: Day One